SEPN compared with RANI: revenue, margins and what each company keeps, and the suppliers and customers both name

SEPNSepterna, Inc.

Mkt capRevenueRevenue

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

Compare

SEPNSepterna, Inc.

RANIRani Therapeutics Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SEPN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.9%▲+22.93%×1.92

May 12 '26±9.9%▲+5.39%×0.55

Q1 FY26±8.3%▼−3.58%×0.43

Q3 FY25±25.7%▼−2.22%×0.09

RANI1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±35.6%▼−0.23%×0.01

= impliedSEPN realized, solidRANI realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

SEPNSepterna, Inc.

43.98▼−2.76%· post 43.98

Mkt cap$2.0BRevenue$27MQ2 FY26Revenue$46MFY25

RANIRani Therapeutics Holdings, Inc.

0.60▼−1.49%· post 0.60

ClosedOct 30 '26

Mkt cap$82.2MRevenue$2MQ2 FY26Revenue—

Compare

ClosedOct 30 '26

SEPNSepterna, Inc.

RANIRani Therapeutics Holdings, Inc.

43.98▼−2.76%post 43.98

Price

0.60▼−1.49%post 0.60

$2.0B

Mkt cap

$82.2M

Q2 FY26$27M

Revenue

$2MQ2 FY26

FY25$46M

Revenue

—

SEPN43.98▼−2.76%vsRANI0.60▼−1.49%ClosedOct 30 '26